Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Austin 78704, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Austin 78704 patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Austin 78704: Gorg! Wellness & Aesthetics and Victory Weight Loss Center. Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Weight-Loss Injections seen from Austin 78704, without the jargon. This page is a starting point for comparing the injectable options available via telehealth before a medical evaluation.
Eligibility is not fixed: a patient who is not eligible today may become so if their medical situation changes. The goal of the evaluation is not to screen for the sake of screening, but to make sure the expected benefit outweighs the risks.
With a local obesity rate around 38.4% and 16.6% uninsured, demand for Weight-Loss Injections runs high around Austin 78704. Weight-Loss Injections belongs to the 'Category: injectable GLP-1 and dual-agonist treatments' class and is given as a weekly subcutaneous injections, most often at home. Local landmark: Gorg! Wellness & Aesthetics (1529 Barton Springs Rd 32 2nd Floor, Austin, TX 78704), rated 5/5 across 65 reviews. On the cost side, expect about $200-600/month depending on the molecule and format (compounded vs brand). depending on the format (brand vs compounded).
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
The two main ones are semaglutide (GLP-1) and tirzepatide (dual GIP/GLP-1). Tirzepatide shows higher average loss in trials, but the choice depends on tolerance and cost.
The approved molecules (semaglutide, tirzepatide) have a documented safety profile under medical supervision; they require a prescription and monitoring.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.